Tardy-Poncet B - Search Results

1

Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia.

Elalamy I, Tardy-Poncet B, Mulot A, de Maistre E, Pouplard C, Nguyen P, Cleret B, Gruel Y, Lecompte T, Tardy B; GEHT HIT Study Group. Elalamy I, et al. Thromb Res. 2009 Nov;124(5):554-9. doi: 10.1016/j.thromres.2009.04.002. Epub 2009 May 1. Thromb Res. 2009. PMID: 19410277

2

[Thrombopenia caused by low molecular weight heparin].

Tardy B, Page Y, Tardy-Poncet B, Comtet C, Zeni F, Bertrand JC. Tardy B, et al. Therapie. 1990 Sep-Oct;45(5):453. Therapie. 1990. PMID: 2175456 French. No abstract available.

3

Pentosan polysulfate-induced thrombocytopenia and thrombosis.

Tardy-Poncet B, Tardy B, Grelac F, Reynaud J, Mismetti P, Bertrand JC, Guyotat D. Tardy-Poncet B, et al. Am J Hematol. 1994 Mar;45(3):252-7. doi: 10.1002/ajh.2830450312. Am J Hematol. 1994. PMID: 7507640 Review.

4

Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.

Tardy/Poncet B, Mahul P, Beraud AM, Favre JP, Tardy B, Guyotat D. Tardy/Poncet B, et al. Br J Haematol. 1995 Aug;90(4):969-70. doi: 10.1111/j.1365-2141.1995.tb05229.x. Br J Haematol. 1995. PMID: 7669684 No abstract available.

5

Low molecular weight heparin for Hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation.

Tardy B, Tardy-Poncet B, Page Y, Décousus H, Guyotat D, Bertrand JC. Tardy B, et al. Cancer. 1993 May 1;71(9):2882-3. doi: 10.1002/1097-0142(19930501)71:9<2882::aid-cncr2820710937>3.0.co;2-r. Cancer. 1993. PMID: 8385569 No abstract available.

6

[Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].

Tardy-Poncet B, Reynaud J, Tardy B, Mahul P, Mismetti P, Beraud AM, Rebaud MA, Bayon M, Guyotat D. Tardy-Poncet B, et al. Presse Med. 1996 May 4-11;25(16):751-5. Presse Med. 1996. PMID: 8692750 French.

7

Effects of long travels in sitting position in elderly volunteers on biological markers of coagulation activation and fibrinolysis.

Tardy B, Tardy-Poncet B, Bara L, Laporte-Simitsidis S, Rascle F, Samama MM, Guyotat D, Bertrand JC. Tardy B, et al. Thromb Res. 1996 Jul 15;83(2):153-60. doi: 10.1016/0049-3848(96)00116-8. Thromb Res. 1996. PMID: 8837314

8

Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism.

Tardy B, Tardy-Poncet B, Viallon A, Lafond P, Page Y, Venet C, Bertrand JC. Tardy B, et al. Thromb Haemost. 1998 Jan;79(1):38-41. Thromb Haemost. 1998. PMID: 9459319

9

Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.

Tardy B, Tardy-Poncet B, Viallon A, Piot M, Mazet E. Tardy B, et al. Thromb Haemost. 1998 Sep;80(3):530. Thromb Haemost. 1998. PMID: 9759647 No abstract available.

10

Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.

Tardy-Poncet B, Tardy B, Reynaud J, Mahul P, Mismetti P, Mazet E, Guyotat D. Tardy-Poncet B, et al. Chest. 1999 Jun;115(6):1616-20. doi: 10.1378/chest.115.6.1616. Chest. 1999. PMID: 10378558 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters